 |
|
The Prevalence of Diabetic Retinopathy Among Adult Type 1 Diabetic Persons in the United States
Monique S. Roy, MD;
Ronald Klein, MD, MPH;
Benita J. O'Colmain, MPH;
Barbara E. K. Klein, MD, MPH;
Scot E. Moss, MA;
John H. Kempen, MD, PhD
Arch Ophthalmol. 2004;122:546-551.
Objective To estimate the US prevalence of diabetic retinopathy (DR) among persons with type 1 diabetes mellitus (DM).
Methods Prevalence data from the New Jersey 725 and Wisconsin Epidemiologic Study of Diabetic Retinopathy were used to estimate the prevalence of DR by age, gender, and race among persons 18 years and older having type 1 DM diagnosed before age 30 years. Severity of DR was determined via masked grading of 7-field stereoscopic fundus photographs. Any DR was defined as retinopathy severity level of 14 or more; and vision-threatening retinopathy, as retinopathy severity level of 50 or more, the presence of clinically significant macular edema, or both. The estimates of the prevalence of DR among persons with type 1 DM were applied to the estimated number of persons with type 1 DM diagnosed before age 30 years in the 2000 US population to obtain prevalence estimates of DR due to type 1 DM in the general population.
Results Among 209 million Americans 18 years and older, an estimated 889 000 have type 1 DM diagnosed before age 30 years. Among persons with type 1 DM, the crude prevalences of DR of any level (74.9% vs 82.3% in black and white persons, respectively) and of vision-threatening retinopathy (30.0% vs 32.2%, respectively) are high. The prevalence of DR due to type 1 DM diagnosed before age 30 years in the general population 18 years and older is estimated at 767 000 persons having DR of any level (0.37%), and 376 000 persons having vision-threatening retinopathy (0.18%).
Conclusion Retinopathy due to type 1 DM is an important public health problem in the United States, affecting 1 per 300 persons 18 years and older, and 1 per 600 persons with advanced, vision-threatening retinopathy.
From the Institute of Ophthalmology and Visual Science, the University of Medicine and Dentistry–New Jersey Medical School, Newark, (Dr Roy); Department of Ophthalmology and Visual Sciences, Madison, Wis (Drs R. Klein and B. E. K. Klein and Mr Moss); Department of Epidemiology and Biostatistics, School of Public Health and Health Services, Washington, DC (Ms O'Colmain); Macro International Inc, Calverton, Md (Ms O'Colmain); Department of Ophthalmology, The Johns Hopkins University School of Medicine (Dr Kempen), and Department of Epidemiology, Bloomberg School of Public Health, Baltimore, Md (Dr Kempen). The authors have no relevant financial interest in this article.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Abnormal Retinal Vascular Oxygen Tension Response to Light Flicker in Diabetic Rats
Blair et al.
IOVS 2009;50:5444-5448.
ABSTRACT
| FULL TEXT
A Systematic Meta-Analysis of Genetic Association Studies for Diabetic Retinopathy
Abhary et al.
Diabetes 2009;58:2137-2147.
ABSTRACT
| FULL TEXT
The Sensitivity and Specificity of Nonmydriatic Digital Stereoscopic Retinal Imaging in Detecting Diabetic Retinopathy
Ahmed et al.
Diabetes Care 2006;29:2205-2209.
ABSTRACT
| FULL TEXT
Lower-than-Expected Prevalence and Severity of Retinopathy in an Incident Cohort followed during the First 4-14 Years of Type 1 Diabetes: The Wisconsin Diabetes Registry Study
LeCaire et al.
Am J Epidemiol 2006;164:143-150.
ABSTRACT
| FULL TEXT
Inflammatory Markers and Diabetic Retinopathy in Type 1 Diabetes
Izuora et al.
Diabetes Care 2005;28:714-715.
FULL TEXT
The Prevalence of Diabetic Retinopathy Among Adults in the United States
Arch Ophthalmol 2004;122:552-563.
|
